Hearing implant pioneer Cochlear shares plunge to eye-watering decade-low after second major profit downgrade

Cochlear was sold off after dramatically downgrading its full-year earnings guidance for the second time in just over two months, with the Trump administration’s raid on Medicaid funding playing a huge role.

Go to News Site